Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4456-4462, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Mycoplasma penetrans
Endonuclease P40 as a Potential Pathogenic Determinant
Mourad
Bendjennat,1,2
Alain
Blanchard,3
Mohammed
Loutfi,2
Luc
Montagnier,3 and
Elmostafa
Bahraoui1,*
Laboratory of Immunovirology UFR SVT,
University of Paul Sabatier, 31062 Toulouse,1
and Department of AIDS and Retroviruses, Viral Oncology
Unit, CNRS URA 1157, Institut Pasteur, 75724 Paris,3 France, and Laboratory of
Biochemistry, University Hassan II, Casablanca,
Morocco2
Received 25 March 1999/Returned for modification 28 April
1999/Accepted 28 May 1999
 |
ABSTRACT |
Recently, we reported the purification to homogeneity and
characterization of Ca2+- and Mg2+-dependent
endonuclease P40 produced by Mycoplasma penetrans (M. Bendjennat, A. Blanchard, M. Loutfi, L. Montagnier, and E. Bahraoui, J. Bacteriol. 179; 2210-2220, 1997), a mycoplasma which was isolated for
the first time from the urine of human immunodeficiency virus-infected patients. To evaluate how this nuclease could interact with host cells,
we tested its effect on CEM and Molt-4 lymphocytic cell lines and on
peripheral blood mononuclear cells. We observed that 10
7
to 10
9 M P40 is able to mediate a cytotoxic effect. We
found that 100% of cells were killed after 24 h of incubation
with 10
7 M P40 while only 40% cytotoxicity was obtained
after 72 h of incubation with 10
9 M P40.
Phase-contrast microscopy observations of P40-treated cells revealed
morphological changes, including pronounced blebbing of the plasma
membrane and cytoplasmic shrinkage characteristic of programmed cell
death, which is in agreement with the internucleosomal fragmentation of
P40-treated cell DNA as shown by agarose gel electrophoresis. We showed
that 125I-radiolabeled or fluorescein
isothiocyanate-labeled P40 was able to bind specifically in a
dose-dependent manner to the cell membrane of CEM cells, which
suggested that the cytotoxicity of P40 endonuclease was mediated by its
interaction with the cell surface receptor(s). The concentration of
unlabeled P40 required to inhibit by 50% the formation of
125I-P40-CEM complexes was about 3 × 10
9 M, indicating a high-affinity interaction. Both P40
interaction and cytotoxicity are Ca2+ dependent. Our
results suggest that the cytotoxicity of M. penetrans observed in vitro is mediated at least partially by secreted P40, which, after interaction with host cells, can induce an apoptosis-like death. These results strongly suggest a major role of mycoplasmal nucleases as potential pathogenic determinants.
 |
INTRODUCTION |
Mycoplasmas, the smallest
self-replicating organisms, are prokaryotes which are parasites of a
large variety of animal and plant species (reviewed in reference
19). Several mycoplasma species have been isolated
in humans, including Mycoplasma fermentans, M. genitalium, M. hominis, M. pneumoniae, and
Ureaplasma urealyticum. Some of these mollicutes are
genuinely associated with a pathologic condition, but most seemingly
constitute a part of the normal human microflora (reviewed in
references 33 and 35). M. penetrans is the latest mycoplasma to be isolated from humans; it
was first isolated from the urine of patients infected by human
immunodeficiency virus (HIV) (17). This mycoplasma can enter
the cells it infects in vitro, hence its name (2, 16), and
subsequently can develop a cytopathic effect in the parasitized cells
(11, 18). Epidemiological studies by enzyme-linked
immunosorbent assay and Western blotting revealed a relatively high
frequency of anti-M. penetrans antibodies in HIV-infected
homosexual patients. A total of 18% of HIV seropositive patients
clinically asymptomatic and at least 35% of those developing AIDS were
seropositive for M. penetrans, whereas this prevalence was
less than 2% in all persons not infected by HIV (12, 51). There is currently no particular pathology associated with infection by
M. penetrans, although an epidemiological study has
suggested a link between the presence of anti-M. penetrans
antibodies and a faster progression of HIV disease (13).
Recently, there was a report describing a female patient infected by
M. penetrans who was seronegative for HIV and who presented
a primary antiphospholipid syndrome. This is the first case associating
a pathological condition with M. penetrans infection;
however, a cause-and-effect relationship remains to be shown
(53).
The cytopathogenicity of mycoplasmas is believed to involve, at least
in vitro, the production of different factors including exotoxins
(6, 50), phospholipases (41, 43, 45),
immunoglobulin A proteases (38, 48), ureases (26,
42), membrane hemolysins (23), and/or oxidative free
radicals (7, 47). However, there are few studies that
clearly link a specific activity (other than adherence or
adherence-related proteins) to virulence in mycoplasmas, primarily
because of the lack of genetic systems and the difficulty in
identifying well-defined mutants lacking these activities. Mycoplasma
nucleases were first reported by Razin et al. (37). These
enzymes have been suggested to be involved in DNA repair and
recombination and in restricting foreign DNA. In addition, several
authors have reported that the nucleic acids of host cells may be
targets for soluble nucleases secreted into the extracellular medium
and/or bound to mycoplasma membranes. Indeed, these bacteria are
deficient in nucleotide biosynthesis pathways. Their nuclease
activities, on the other hand, are developed as a means of producing
the nucleic acid precursors required for their metabolism by digesting
the DNA and RNA of the cells they parasitize (24, 25, 34,
36). As a consequence, we and others have shown that nucleases
produced by contaminating mycoplasmas were responsible for the apparent
absence of reverse transcriptase activity in the supernatants from
HIV-producing cell lines (31, 44). While many mycoplasmas
produce extracellular nucleases, only a limited number of bacteria do
(4). Furthermore, these nuclease activities of mycoplasmas
were recently implicated in the induction of apoptosis characterized by
the internucleosomal fragmentation of the chromatin of infected cells
(27, 28, 46).
To determine the potential pathogenic role of mycoplasma nucleases, we
studied the effect of M. penetrans endonuclease P40 on
lymphocytes. We have recently shown that P40 is synthesized in the form
of 50-kDa precursor (P50) and is secreted by the microorganism probably
after processing of P50. This precursor is associated with the
mycoplasmal membrane and is soluble only in the presence of detergent.
P40 was purified to homogeneity, and its characterization showed that
it is a Ca2+- and Mg2+-dependent endonuclease.
When incubated with native nuclei extracted from human lymphocytes, the
enzyme can diffuse into the nuclei and degrade chromatin into
oligonucleosomal units similar to those observed in apoptotic cells
(3). In this work, we extend our previous studies by
presenting direct evidence of the capacity of purified M. penetrans endonuclease P40 to bind specifically to T lymphocytes
and alter the cells by inducing physiological changes characteristic of apoptosis.
 |
MATERIALS AND METHODS |
Cell cultures.
CEM and Molt-4 lymphocytic cells lines were
cultured in RPMI 1640 medium supplemented with 10% fetal calf serum
(Flow, Irvine, Scotland), 2 mM glutamine, and 1% antibiotic stock
solution (Gibco, Paisley, Scotland) in a humidified 5% CO2
atmosphere. Peripheral blood mononuclear cells (PBMCs) were prepared by
Ficoll-Hypaque gradient centrifugation of blood from HIV-seronegative
donors, and cultured in complete RPMI 1640 medium. All cells were
harvested in the exponential growth phase for use in experiments.
M. penetrans GTU-54-6A1 was cultured in PPLO broth
containing 10% (vol/vol) heat-inactivated (56°C for 30 min) horse
serum, 0.25% (wt/vol) glucose, and 0.002% phenol red (pH 7.8). The
cultures were incubated statically at 37°C.
Purification of endonuclease P40.
Active endonuclease P40
was purified from M. penetrans by the method of Bendjennat
et al. (3). Briefly, 40-kDa nuclease was extracted in
aqueous phase from M. penetrans cells by Triton X-114 phase
fractionation. Aqueous P40 was further purified by chromatography on
Superdex 75 and chelating Sepharose (Zn2+ form) columns.
The purity and activity of the endonuclease preparation were assessed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (silver
nitrate staining) and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis nuclease assay, respectively.
Cytotoxicity assay.
The cytotoxic activity of purified
M. penetrans endonuclease was evaluated by the trypan blue
dye exclusion test. Cells were seeded at a density of 104
cells per well in 96-well flat-bottom microtiter plates and incubated for the desired times at 37°C in culture medium, in the absence or
presence of protein P40 (10
9 to 10
7 M).
Survival was calculated as the percentage of the unstained cells.
Percent cytotoxicity is the difference between control (100%) and the
percent survival.
DNA extraction and electrophoresis.
Cells, previously
treated or not with P40, were lysed on ice for 20 min in 5 mM Tris-HCl
(pH 7.4) containing 0.5% Triton X-100 and 5 mM EDTA. The cells were
then centrifuged at 12,000 × g for 30 min at 4°C to
separate high-molecular-weight chromatin from nucleosomal DNA
fragments. Supernatants were collected, incubated with proteinase K
(100 µg/ml for 16 h at 37°C), and brought to 200 mM NaCl.
Nucleic acids were precipitated with isopropanol, washed with 70%
ethanol, resuspended in 10 mM Tris-HCl (pH 8)-10 mM EDTA, and treated
with RNase (50 µg/ml for 4 h at 37°C). The DNA from the final
step was separated by electrophoresis on 2% agarose gels in
Tris-acetate-EDTA buffer and stained with ethidium bromide.
Iodination of endonuclease P40.
Endonuclease P40 was
iodinated by a iodogen standard procedure. A 10-µg quantity of
M. penetrans P40 in 100 µl of phosphate-buffered saline
(PBS) (pH 7.4) and 0.5 mCi of Na125I (13 to 17 mCi/µg)
were added to a tube precoated with 75 nmol of iodogen and incubated
for 10 min at room temperature. The reaction was stopped by adding 10 µl of tyrosine (9 mg/ml). The iodinated protein was desalted from
free Na125I by filtration through a Sephadex (G-25 PD10
column equilibrated with PBS-0.5% (wt/vol) bovine serum albumin
(BSA). The specific radioactivity was about 45 µCi/µg.
Binding of M. penetrans endonuclease to CEM cells
determined by the direct radiolabeling assay.
The assay was
performed as follows. Cells were incubated with 100 µl of various
preparations of iodinated protein in PBS (pH 7.4)-0.5% BSA at 37°C
for the desired time. After the cells were washed twice with buffer,
bound radioactivity was counted in a gamma counter. Inhibition of
125I-P40 binding to CEM cells by native protein was
performed as described above, except that the cells were first
incubated with native endonuclease P40 at 37°C for 10 min before the
addition of 125I-P40 for the same length of time.
Binding of Endonuclease P40 analyzed by flow
cytofluorometry.
P40 protein was solubilized in 250 µl of 100 mM
sodium bicarbonate buffer (pH 9.5) and incubated in the dark with
fluorescein isothiocyanate (FITC) for 2 h at 25°C. The reaction
mixture was then loaded on a Sephadex G-25 PD10 column equilibrated
with 0.5 M acetic acid. CEM cells (106) were incubated for
4 h at 37°C with different dilutions of P40 coupled to FITC in
100 µl of PBS (pH 7.4)-0.5% BSA. The cells were washed twice and
fixed in 500 µl of 1% paraformaldehyde. The fluorescence intensity
was measured with a fluorescence-activated cell sorter (Becton
Dickinson). Inhibition of direct binding of P40 to CEM cells was
assayed under the same conditions, except that the native P40 protein
was first incubated with cells at 37°C for 10 min before the
FITC-coupled P40 was added. The same field of cells were visualized by
phase-contrast and fluorescence microscopy with the appropriate filters
and photographed for presentation.
 |
RESULTS |
M. penetrans endonuclease P40-mediated
cytotoxicity.
P40 cytotoxicity was tested on CEM and Molt-4
lymphocytic cell lines and on PBMCs by a standard trypan blue exclusion
assay. The cells (104) were incubated with
10
9, 10
8, and 10
7 M P40, and
the percent cytotoxicity, the difference between control (100%) and
percent survival, was determined after 72 h. The results in Fig.
1 show that the cytotoxicity of P40
toward CEM cells is dose and time dependent. At a high P40
concentration (10
7 M), the maximum effect (100%
cytotoxicity) was observed after 24 h. At 10
8 M,
100% cytotoxicity was obtained only after 72 h of incubation, whereas at 10
9 M, the percent cytotoxicity never
increased beyond 45% even after 72 h of incubation.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Cytotoxicity of M. penetrans endonuclease P40
toward CEM cells. CEM cells were washed and seeded in 96-well plates
(104 cells/200 µl of culture medium) and exposed at time
zero to endonuclease P40 (0 M [ ], 10 9 M [ ],
10 8 M [ ], or 10 7 M [ ]) at 37°C.
Percent cytotoxicity was determined at the defined time points and is
calculated as the difference between control (100%) and percent
survival. Values are means ± standard errors from triplicate
experiments.
|
|
Morphological changes of treated cells were assessed by phase-contrast
microscopy observation (Fig.
2). In
comparison to untreated
cells (Fig.
2A), whose morphology is normal and
which have smooth
membrane surfaces, phase images of P40-treated cells
(Fig.
2B
to E) reveal dramatic changes, including pronounced blebbing
of
the plasma membrane, cytoplasmic shrinkage characteristic of
programmed
cell death, and a significant loss of refractibility. The
release
of DNA from nuclei in nonionic detergent is defined as nuclear
damage. Therefore, the detergent-soluble DNA released by P40 treatment
was analyzed by agarose gel electrophoresis. As shown in Fig.
3 for CEM cells and PBMCs incubated with
P40, such detergent-soluble
DNA was strikingly fragmented in a
characteristic nucleosomal
ladder pattern (Fig.
3, lanes 1 [CEM]
and 2 [PBMCs]). In cases
where no morphological changes
were observed (untreated cells),
there was no DNA fragmentation.
Detergent-insoluble DNA remaining
in the pelleted nuclei showed little
fragmentation (data not shown).

View larger version (118K):
[in this window]
[in a new window]
|
FIG. 2.
The effects of P40 protein on CEM cells in vitro were
assessed by phase-contrast microscopy. CEM cells (104) were
cultured in flat-bottom microtiter plates in the absence or presence of
10 8 M P40. After 24 h, photomicrographs were taken.
(A) Negative control; (B to E) morphological changes of cells incubated
in the presence of P40. Arrows indicate apoptosis-like bodies.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Endonuclease P40-induced internucleosomal DNA
fragmentation. Small supernatant DNA after centrifugation of
detergent-lyzed cells was separated on a 2% agarose gel. CEM cells
(lane 1) and PBMCs (lane 2) (106) were incubated with P40
(10 8 M) for 24 h at 37°C in culture medium. Lanes
3 and 4 contain CEM and PBMC negative controls, respectively. Lane M
contains the 1-kb DNA ladder used as a standard.
|
|
The same cytotoxic effect of P40 on Molt-4 cells and PBMCs was
observed. Although there was a slight difference in the optimum
concentration for inducing cytopathic effect, both cell alteration
and
nuclear damage were also dose and time dependent (data not
shown).
Binding of P40 to CEM cells as studied by direct radiolabeling
assay and direct FITC labeling.
To determine if P40 cytotoxicity
was mediated by a cell membrane-P40 interaction, we tested the binding
capacity of iodinated P40 (125I-P40) to target cells.
The results (Fig. 4A) clearly show that 125I-P40 bound in a dose-dependent manner to CEM cell
when the binding assay was carried out with various concentrations of
125I-P40 and a constant cell number. Analysis of the
time course and stability of binding indicated a peak of binding
capacity at 15 min followed by a significant decrease, finally reaching a steady-state equilibrium (Fig. 4B). This time course of P40 binding
was reproducible when different numbers of cells (1 × 106 to 8 × 108 cells) were incubated with
a constant quantity of P40 (data not shown).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Direct radiolabeling assay analysis of
125I-P40 binding to CEM cells. (A) A 50-µl volume of
cells (106) was incubated with 50 µl of various
125I-P40 dilutions (0 to 106 cpm; 0 to
10 9 M). (B) Time course of 125I-P40
(106 cpm; 10 9 M) binding to CEM cells (8 × 106). (C) Inhibition of 125I-P40 binding
to CEM cells (106) by native protein at 10 8 M
and 37°C. B/B0 corresponds to the binding obtained in the
presence of competitor/binding obtained in the absence of competitor.
After the cells were washed twice with PBS-BSA buffer, bound
radioactivity was counted. Values are means ± standard errors of
triplicate experiments.
|
|
To test if the
125I-P40 decrease observed after 15 min
was due to cell membrane-associated protease activity, the binding
assay
was performed in the presence of protease inhibitors, including
phenylmethylsulfonyl fluoride, pepstatin, leupeptin, and aprotinin.
The
results were similar to those described above, with dose-dependent
curves and maximum binding after 15 min of incubation (data not
shown).
The specificity and affinity of the
125I-P40-CEM cell
interaction was analyzed in a competitive assay with native P40
(unlabeled)
as a competitor. Different concentrations of unlabeled P40
(10
12 to 10
7 M) were incubated with CEM
cells, which were then incubated with
125I-P40. The
results in Fig.
4C show that unlabeled P40 inhibited
125I-P40 binding in a dose-dependent manner. This
inhibition argues
for the specificity of this interaction. The
concentration of
native P40 required to inhibit the formation of
125I-P40-CEM complexes by 50% was about 3 × 10
9 M. This value indicates that P40 binds specifically
and with
high affinity to at least one potential receptor expressed on
CEM
lymphocytes.
The binding and cytotoxicity of P40 toward CEM cells were further
confirmed by FACS analysis with various concentrations of
FITC-labeled
P40. The results in Fig.
5 show the
capacity of P40
to interact with CEM cells in a dose-dependent manner.
In addition,
we observed the cytotoxic effect of P40 in the form of the
appearance
of a small and altered CEM cell population. The percentage
of
this population increased with the quantity of FITC-P40 used.
The
binding capacity of fluorescent P40 to CEM cells was inhibited
by
native protein, as was observed in the
125I-P40
experiments (data not shown), confirming the specificity
of the P40-CEM
cell interaction.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Direct fluorescence labeling of P40 bound to CEM cells
and inducing a cytopathic effect. A total of 106 cells were
incubated with different dilutions of FITC-conjugated P40 (negative
control [A] and 1 × 10 9 [B], 1 × 10 8 [C], 5 × 10 7 [D], and 1 × 10 7 M [E], respectively) for 4 h at 37°C, in
100 µl of PBS, BSA buffer. After the cells were washed, they were
screened by flow cytometry analysis. NC and AC, normal cells and
altered cells, respectively.
|
|
The fluorescence microscopic analysis of CEM cells previously incubated
with FITC-P40 at 10
7 M (the same cells as those analyzed
by fluorescence-activated
cell sorting in Fig.
5E) showed both cell
membrane and intracellular
localization (Fig.
6B and
C) of the FITC-P40. We can note from
the
comparison of the cells observed by phase-contrast and fluorescence
microscopy that the labeled protein was mostly associated with
altered
cells.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 6.
Distribution of staining on fluorescence analysis of CEM
cells from Fig. 5E by fluorescence microscopy. Phase-contrast (A) and
fluorescence (B) microscopy observations. (C) Another field of
fluorescent cells.
|
|
Binding and cytotoxicity-inducing capacities of P40 to CEM cells
are Ca2+ dependent.
We previously showed that the
endonuclease activity of P40 enzyme is Ca2+ and
Mg2+ dependent whereas Zn2+ is inhibitory
(3). The effect of these divalent ions on the binding
capacity of 125I-P40 to CEM cells was therefore tested.
While no effect was observed in the presence of Mg2+ and
Zn2+, Ca2+ caused an increase by more than
threefold in the formation of 125I-P40-cell complexes
(Fig. 7A). This effect of
Ca2+ started at the concentration of 2 mM
CaCl2, and was abolished by the addition of EDTA (data not
shown).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 7.
(A) Effect of Ca2+ on the avidity of
125I-P40 binding. A 50-µl volume of
125I-P40 (2 × 106 cpm, 2 × 10 9 M) in PBS-BSA buffer containing several dilutions
of CaCl2 was added to 50 µl of CEM cells
(106) and incubated at 37°C for 15 min. After the cells
were washed twice with buffer, bound radioactivity was counted. The
effect of Ca2+ on 125I-P40 binding activity
was abolished in the presence of EDTA and was reproducible in Tris and
morpholineproponesulfonic acid (MOPS) buffer instead of PBS. (B)
Effect of Ca2+ on cytotoxicity induced by endonuclease P40.
The cytopathic effect of P40 was assessed as described in the legend to
Fig. 1 (104 cells, 10 8 M P40), except that
cells were cultivated in calcium-free medium. Percent cytotoxicity was
determined at the defined time points. and , cells cultivated
with and without exogenous CaCl2, respectively; ,
P40-treated cells; , P40-treated cells in the presence of
CaCl2. Data are the means ± standard errors.
|
|
The effect of Ca
2+ on induction of the cytopathic effect of
P40 was investigated by first cultivating CEM cells in calcium-free
medium. Then protein P40 was added in the absence or presence
of 2 mM
CaCl
2. The results in Fig.
7B show that the cytopathic
effect of P40 increased about fivefold in the presence of
Ca
2+. It is interesting that P40 remained cytopathic even
in the absence
of Ca
2+, although to a lesser extent. Under
these conditions, no cytotoxicity
was detected with P40-untreated cells
cultivated in Ca
2+-free
medium.
 |
DISCUSSION |
In mycoplasmology, there is a need for a better understanding of
the mechanisms of virulence, associated pathogenicities, and the
effects on host cells. In addition to infecting a large variety of
species including humans, recent estimations have shown that between 30 and 70% of eukaryotic cell cultures are contaminated by mycoplasmas
(9, 10, 32, 40, 52). The most frequent contaminants are
M. hyorhinis, M. orale, M. arginini,
M. fermentans, and Acholeplasma laidlawii
(21).
Mycoplasmas are generally defective in several metabolic pathways, and
their growth requires macromolecular precursors including nucleic acids
from the host and/or the surrounding medium (34). They
cannot synthesize purine and pyrimidine bases de novo (15, 22, 36,
49). Their nuclease activity has been proposed as a mechanism
enabling them to acquire nucleic acids in the form of free bases and/or
oligonucleotides (20, 25, 30, 36, 39). The capacity of some
species, including M. penetrans, to invade the cells they
parasitize suggests that host cell DNA and/or RNA could be a substrate
for these nuclease activities.
Using purified M. penetrans endonuclease P40, we observed
the effect of the protein on lymphocytes. Compared to untreated controls, cells incubated with the endonuclease exhibited considerable cytopathic effects. The alterations included condensation of the cytoplasm, a loss of surface microvillosities, and the appearance of
apoptotic bodies, consistent with the reduction in cell numbers. In
addition, the cytopathic effect of high concentrations
(>10
7 M) of P40 toward lymphocytes is rapid. The nucleic
acids of cells incubated with P40 were analyzed by agarose gel
electrophoresis and showed an oligonucleosomal fragmentation of
chromatin similar to that observed in apoptotic cells.
Binding assays with 125I-P40 showed a dose-dependent
binding of P40 to CEM lymphocytes. Binding exhibits the principal
characteristic of a specific interaction since it is inhibited by
increasing concentrations of unlabeled P40. The concentration of
unlabeled P40 required to inhibit the formation of the
125I-P40-CEM complex by 50% is about 3 × 10
9 M, indicating a high-affinity interaction. The nature
and characteristics of the receptor(s) remain to be defined. It is also
of interest that 125I-P40 binding to lymphocytes
reaches a maximum after 15 min of incubation, decreases thereafter, and
finally reaches a new steady-state equilibrium. We have no formal
explanation for this decrease in P40 binding by CEM cells, but two
hypothesis may be advanced. The first is the degradation of
125I-P40 by cell membrane-bound protease(s). We tested
a range of protease inhibitors in incubations of cells with P40, and
the results are still inconsistent with this hypothesis. The other hypothesis is the release of receptor-P40 complexes into the media after capping on the surface of the cell. This is commonly observed in
lymphocytes during antibody-induced capping of surface proteins. Indeed, before determination of radioactivity, the cells were washed
twice by centrifugation.
Characterizing the interaction parameters of
125I-P40-CEM cells showed that among the divalent ions
tested, only calcium increased binding and the induction of the
cytopathic effect of P40. It was reported that in contrast to
Ca2+-independent inducers of apoptosis (etoposide and
dexamethasone), Ca2+-dependent inducers
(anti-TCR/fas/CD3, ionomycin, and A23187) activate a
Ca2+-dependent cellular endonuclease leading to
oligonucleosomal fragmentation in lymphocytes (1, 8, 14,
29). Nevertheless, the observed oligonucleosomal fragmentation of
lymphocyte chromatin in the presence of P40 appears only partially due
to the activity of the Ca2+-dependent cellular
endonuclease. Indeed, P40 apparently induces another pathway for
activating cell death that is Ca2+ independent. When
Ca2+ was absent from the culture medium, P40 was still
cytotoxic toward lymphocytes but to a lesser degree. It is interesting
that in the absence of Ca2+ and with Mg2+
present, P40 retained 60% of its nuclease activity (3).
M. penetrans is both invasive and attached to the outer
surface of cells, as shown by electron microscopic observation (2, 5, 16). The present work shows the cytotoxic effect of P40 toward
lymphocytes in vitro that may be susceptible to infection in vivo by
M. penetrans. This microorganism can exert two simultaneous effects via P40: (i) a cytotoxic effect caused by P40 secreted by
extracellular M. penetrans, and (ii) a second effect caused by P40 secreted by M. penetrans inside the cells. The latter
form of endonuclease P40 could rapidly and directly be at the origin of
chromatin degradation that causes cell death. We thus propose M. penetrans endonuclease P40 as a potential virulence factor in
infection caused by this mycoplasma.
These data suggest that in a large majority of mycoplasmal infections,
parasite nuclease activities can participate directly in cell death by
apoptosis, in addition to the mechanisms inducing cellular necrosis.
The studies of Paddenberg et al. in vitro, using cells contaminated by
M. hyorhinis, clearly shows the capacity of mycoplasmal
nucleases to cause cell death by apoptosis (27, 28). In a
recently published report (46), it was shown that M. bovis infection of cultured cells leads also to an increased sensitivity to various inducers of apoptosis. Interestingly, a mycoplasma nuclease was recovered from nuclear fractions obtained from
these infected cells. These results are consistent with our present
data and indicate the key role of nucleases in the mycoplasma-induced cytopathic effects. Taken together, our results allowed us to postulate
that nucleases secreted by M. penetrans may interact with
and then be taken up by parasitized cells. Thus, internalized M. penetrans P40 nuclease may act directly as a cytotoxic factor by
cleaving DNA and/or RNA of host cells to induce cells into apoptosis-like death. We believe that this phenomenon should be considered when interpreting apoptosis observed in eukaryotic cells
before invoking other mechanisms. Finally, the fact that this
endonuclease activity of M. penetrans can be implicated, at
least in vitro, as a potential factor in the degradation of the nucleic
acids of parasitized cells suggests a potential role of mycoplasmal
nucleases as pathogenic factors. The pathophysiological involvement of
this phenomenon remains to be shown in vivo.
 |
ACKNOWLEDGMENTS |
This work was supported by la Fondation pour la Recherche
Medicale and by Ensemble contre le SIDA (SIDACTION).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Immunovirology UFR SVT, University of Paul Sabatier, Bât. 4, R. 3, 118 route de Narbonne, 31062 Toulouse, France. Phone: 33 5 61 55 86 67. Fax: 33 5 61 55 86 06. E-mail: bahraoui{at}cict.fr.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Alnemri, E. S., and G. Litwack.
1989.
Glucocorticoid-induced lymphocytolysis is not mediated by an induced endonuclease.
J. Biol. Chem.
264:4104-4111[Abstract/Free Full Text].
|
| 2.
|
Andreev, J.,
Z. Borovsky,
I. Rosenshine, and S. Rottem.
1995.
Invasion of HeLa cells by Mycoplasma penetrans and the induction of tyrosine phosphorylation of a 145 kDa host cell protein.
FEMS Microbiol. Lett.
132:189-194[Medline].
|
| 3.
|
Bendjennat, M.,
A. Blanchard,
M. Loutfi,
L. Montagnier, and E. Bahraoui.
1997.
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease.
J. Bacteriol.
179:2210-2220[Abstract/Free Full Text].
|
| 4.
|
Benedik, M. J., and U. Strych.
1998.
Serratia marcescens and its extracellular nuclease.
FEMS Microbiol. Lett.
165:1-13[Medline].
|
| 5.
|
Blanchard, A., and L. Montagnier.
1994.
Aids-associated mycoplasmas.
Annu. Rev. Microbiol.
48:687-712[Medline].
|
| 6.
|
Bredt, W.
1976.
Pathogenicity factors of mycoplasmas.
Infection
4:9-12[Medline].
|
| 7.
|
Brown, U. H.,
A. H. Brightman,
B. W. Fenwick, and M. A. Rider.
1998.
Infections bovine keratoconjunctivitis: a review.
J. Vet. Intern. Med.
12:259-266[Medline].
|
| 8.
|
Cohen, J. J., and R. C. Duke.
1984.
Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.
J. Immunol.
132:38-42[Abstract].
|
| 9.
|
Coronato, S.,
D. Vullo, and C. E. Coto.
1994.
A simple method to eliminate mycoplasma from cell cultures.
J. Virol. Methods
46:85-94[Medline].
|
| 10.
|
Fleckenstein, E.,
C. C. Uphoff, and H. G. Drexler.
1994.
Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
Leukemia
8:1424-1434[Medline].
|
| 11.
|
Giron, J. A.,
M. Lange, and J. B. Baseman.
1996.
Adherence, fibronectin binding, and induction of cytoskeleton reorganization in cultured human cells by Mycoplasma penetrans.
Infect. Immun.
64:197-208[Abstract].
|
| 12.
|
Grau, O.,
B. Slizevicz,
P. Tuppin,
V. Launay,
E. Bourgeois,
N. Sagot,
A. Lafeuillade,
H. Bachelez,
J. P. Clauvel, et al.
1995.
Association of Mycoplasma penetrans with human immunodeficiency virus infection.
J. Infect. Dis.
172:672-681[Medline].
|
| 13.
|
Grau, O.,
P. Tuppin,
B. Slizevicz,
V. Launay,
C. Goujard,
E. Bahraoui,
J. F. Delfraissy, and L. Montagnier.
1998.
A longitudinal study of seroreactivity against Mycoplasma penetrans in HIV infected homosexual men: association with disease progression.
AIDS Res. Hum. Retroviruses
14:664-667.
|
| 14.
|
Lennon, S. V.,
S. A. Kilfeather,
M. B. Hallett,
A. K. Campbell, and T. G. Cotter.
1992.
Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells.
Clin. Exp. Immunol.
87:465-471[Medline].
|
| 15.
|
Liska, B., and P. F. Smith.
1974.
Requirements of Acholeplasma laidlawii A, strain LA 1, for nucleic acid precursors.
Folia Microbiol.
19:107-117.
|
| 16.
|
Lo, S. C.,
M. M. Hayes,
H. Kotani,
P. F. Pierce,
D. J. Wear,
P. B. Newton III,
J. G. Tully, and J. W. Shih.
1993.
Adhesion onto and invasion into mammalian cells by Mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDS.
Mod. Pathol.
6:276-280[Medline].
|
| 17.
|
Lo, S. C.,
M. M. Hayes,
R. Y. Wang,
P. F. Pierce,
H. Kotani, and J. W. Shih.
1991.
Newly discovered mycoplasma isolated from patients infected with HIV.
Lancet
338:1415-1418[Medline].
|
| 18.
|
Lo, S. C.,
M. M. Hayes,
J. G. Tully,
R. Y. Wang,
H. Kotani,
P. F. Pierce,
D. L. Rose, and J. W. Shih.
1992.
Mycoplasma penetrans sp. nov. from the urogenital tract of patients with AIDS.
Int. J. Syst. Bacteriol.
42:357-364[Abstract/Free Full Text].
|
| 19.
|
Maniloff, J.,
R. N. McElhaney,
L. R. Finch, and J. B. Baseman (ed.).
1992.
Mycoplasmas: molecular biology and pathogenesis.
ASM Press, Washington, D.C.
|
| 20.
|
Marcus, P. I., and I. Yoshida.
1990.
Mycoplasmas produce double-stranded ribonuclease.
J. Cell. Physiol.
143:416-419[Medline].
|
| 21.
|
McGarrity, G. J.,
H. Kotani, and G. H. Butler.
1992.
Mycoplasmas and tissue culture cells, p. 445-454.
In
J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. ASM Press, Washington, D.C.
|
| 22.
|
McIvor, R. S., and G. E. Kenny.
1978.
Differences in incorporation of nucleic acid bases by various Mycoplasma and Acholeplasma species.
J. Bacteriol.
135:483-489[Abstract/Free Full Text].
|
| 23.
|
Minion, F. C., and K. J. Jarvill-Taylor.
1994.
Membrane-associated hemolysin activities in mycoplasmas.
FEMS Microbiol. Lett.
116:101-106[Medline].
|
| 24.
|
Minion, F. C.,
K. J. Jarvill-Taylor,
D. E. Billings, and E. Tigges.
1993.
Membrane-associated nuclease activities in mycoplasmas.
J. Bacteriol.
175:7842-7847[Abstract/Free Full Text].
|
| 25.
|
Minion, F. C., and J. D. Goguen.
1986.
Identification and preliminary characterization of external membrane-bound nuclease activities in Mycoplasma pulmonis.
Infect. Immun.
51:352-354[Abstract/Free Full Text].
|
| 26.
|
Neyrolles, O.,
S. Ferris,
N. Behbahani,
L. Montagnier, and A. Blanchard.
1996.
Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli.
J. Bacteriol.
178:647-655[Abstract/Free Full Text].
|
| 27.
|
Paddenberg, R.,
A. Weber,
S. Wulf, and H. G. Mannherz.
1998.
Mycoplasma nucleases able to induce internucleosomal DNA degradation in cultured cells possess many characteristics of eukaryotic apoptotic nucleases.
Cell Death Differ.
5:517-528.
[Medline] |
| 28.
|
Paddenberg, R.,
S. Wulf,
A. Weber,
P. Heimann,
L. A. Beck, and H. G. Mannherz.
1996.
Internucleosomal DNA fragmentation in cultured cells under conditions reported to induce apoptosis may be caused by mycoplasma endonucleases.
Eur. J. Cell Biol.
71:105-119[Medline].
|
| 29.
|
Peitsch, M. C.,
B. Polzar,
H. Stephan,
T. Crompton,
H. MacDonald,
H. G. Mannherz, and J. Tschopp.
1993.
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death).
EMBO J.
12:371-377[Medline].
|
| 30.
|
Pollack, J. P., and P. J. Hoffmann.
1982.
Properties of the nucleases of mollicutes.
J. Bacteriol.
152:538-541[Abstract/Free Full Text].
|
| 31.
|
Quillent, C.,
O. Grau,
F. Clavel,
L. Montagnier, and A. Blanchard.
1994.
Inhibition of HIV type 1 reverse transcriptase assay by nucleases produced by contaminating mycoplasmas.
AIDS Res. Hum. Retroviruses
10:1251-1257[Medline].
|
| 32.
|
Rawadi, G., and O. Dussurget.
1995.
Advances in PCR-based detection of mycoplasmas contaminating cell cultures.
PCR Methods Appl.
4:199-208[Medline].
|
| 33.
|
Razin, S., and M. F. Barile (ed.).
1985.
The Mycoplasmas
In
Mycoplasma pathogenicity., vol. 4. Academic Press, Inc., New York, N.Y.
|
| 34.
|
Razin, S.
1978.
The mycoplasmas.
Microbiol. Rev.
42:414-470[Free Full Text].
|
| 35.
|
Razin, S. (ed.).
1992.
The prokaryotes, vol. 2.
2nd ed.19371959Springer-VerlagNew York, N.Y
|
| 36.
|
Razin, S., and B. C. J. B. Knight.
1960.
The effect of ribonucleic acid and deoxyribonucleic acid on the growth of mycoplasma.
J. Gen. Microbiol.
22:504-519[Abstract/Free Full Text].
|
| 37.
|
Razin, S.,
L. Knyszynski, and Y. Lifshitz.
1964.
Nucleases of mycoplasmas.
J. Gen. Microbiol.
36:323-331[Abstract/Free Full Text].
|
| 38.
|
Robertson, J. A.,
M. E. Stemler, and G. W. Stemke.
1984.
Immunoglobulin A protease activity of Ureaplasma urealyticum.
J. Clin. Microbiol.
19:255-258[Abstract/Free Full Text].
|
| 39.
|
Roganti, F. S., and A. L. Rosenthal.
1983.
DNases of Acholeplasma spp.
J. Bacteriol.
155:802-805[Abstract/Free Full Text].
|
| 40.
|
Rottem, S., and M. F. Barile.
1993.
Beware of mycoplasmas.
Trends Biotechnol.
11:143-151[Medline].
|
| 41.
|
Rottem, S.,
M. Hasin, and S. Razin.
1973.
Differences in susceptibility to phospholipase C of free and membrane-bound phospholipids of Mycoplasma hominis.
Biochim. Biophys. Acta
323:520-531[Medline].
|
| 42.
|
Ruifu, Y.,
Z. Minli,
Z. Guo, and X. Wang.
1997.
Biovar diversity is reflected by variations of genes encoding urease of Ureaplasma urealyticum.
Microbiol. Immunol.
41:625-627[Medline].
|
| 43.
|
Salman, M., and S. Rottem.
1995.
The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity.
Biochim. Biophys. Acta
1235:369-377[Medline].
|
| 44.
|
Shang, H.,
Y. Miyakawa,
T. Sasaki,
H. Nakashima, and M. Ito.
1995.
Suppression of HIV-1 reverse transcriptase activity by culture supernatants of mycoplasmas.
Microbiol. Immunol.
39:987-993[Medline].
|
| 45.
|
Shibata, K.,
T. Sasaki, and T. Watanabe.
1995.
AIDS-associated mycoplasmas possess phospholipases C in the membrane.
Infect. Immun.
63:4174-4177[Abstract].
|
| 46.
|
Sokolova, I. A.,
A. T. Vaughan, and N. N. Khodarev.
1998.
Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s).
Immunol. Cell Biol.
76:526-534[Medline].
|
| 47.
|
Somerson, N. L.,
B. E. Walls, and R. M. Chanock.
1965.
Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide.
Science
150:226-228[Abstract/Free Full Text].
|
| 48.
|
Spooner, R. K.,
W. C. Russell, and D. Thirkell.
1992.
Characterization of the immunoglobulin A protease of Ureaplasma urealyticum.
Infect. Immun.
60:2544-2546[Abstract/Free Full Text].
|
| 49.
|
Stanbridge, E. J.,
L. Hayflick, and F. T. Perkins.
1971.
Modification of amino-acid concentrations induced by mycoplasmas in cell culture medium.
Nat. (London) New Biol.
232:242-244.
|
| 50.
|
Tully, J. G.
1981.
Mycoplasmal toxins.
Isr. J. Med. Sci.
17:604-607[Medline].
|
| 51.
|
Wang, R. Y.,
J. W. Shih,
T. Grandinetti,
P. F. Pierce,
M. M. Hayes,
D. J. Wear,
H. J. Alter, and S. C. Lo.
1992.
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients.
Lancet
340:1312-1316[Medline].
|
| 52.
|
Uphoff, C. C.,
S. M. Gignac, and H. G. Drexler.
1992.
Mycoplasma contamination in human leukemia cell lines. I. Comparison of various detection methods.
J. Immunol. Methods
149:43-54[Medline].
|
| 53.
|
Yanez, A.,
L. Cedillo,
O. Neyrolles,
E. Alonso,
M. C. Prevost,
J. Rojas,
H. L. Watson,
A. Blanchard, and G. H. Cassell.
1999.
Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome.
Emerg. Infect. Dis.
5:164-167[Medline].
|
Infection and Immunity, September 1999, p. 4456-4462, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Accetto, T., Avgustin, G.
(2007). Studies on Prevotella nuclease using a system for the controlled expression of cloned genes in P. bryantii TC1-1. Microbiology
153: 2281-2288
[Abstract]
[Full Text]
-
Schmidt, J. A., Browning, G. F., Markham, P. F.
(2007). Mycoplasma hyopneumoniae mhp379 Is a Ca2+-Dependent, Sugar-Nonspecific Exonuclease Exposed on the Cell Surface. J. Bacteriol.
189: 3414-3424
[Abstract]
[Full Text]
-
Hunt, M. E., Brown, D. R.
(2005). Mycoplasma alligatoris Infection Promotes CD95 (FasR) Expression and Apoptosis of Primary Cardiac Fibroblasts. CVI
12: 1370-1377
[Abstract]
[Full Text]
-
Fontaine, M. C., Perez-Casal, J., Willson, P. J.
(2004). Investigation of a Novel DNase of Streptococcus suis Serotype 2. Infect. Immun.
72: 774-781
[Abstract]
[Full Text]
-
Rottem, S.
(2003). Interaction of Mycoplasmas With Host Cells. Physiol. Rev.
83: 417-432
[Abstract]
[Full Text]
-
Rocha, E. P. C., Blanchard, A.
(2002). Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution. Nucleic Acids Res
30: 2031-2042
[Abstract]
[Full Text]
-
Chambaud, I., Heilig, R., Ferris, S., Barbe, V., Samson, D., Galisson, F., Moszer, I., Dybvig, K., Wroblewski, H., Viari, A., Rocha, E. P.C., Blanchard, A.
(2001). The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis. Nucleic Acids Res
29: 2145-2153
[Abstract]
[Full Text]